$CSTAF
Constellation Acquisition Corp I

2024 Q3 Form 10-Q Financial Statement

#000121390024098449 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $731.3K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $731.3K
YoY Change 163.67%
Operating Profit -$245.0K -$731.3K
YoY Change -66.5% 163.67%
Interest Expense $554.0K
YoY Change -65.71%
% of Operating Profit
Other Income/Expense, Net $282.7K $1.038M
YoY Change -72.77% -66.83%
Pretax Income $306.9K
YoY Change -89.24%
Income Tax
% Of Pretax Income
Net Earnings $37.70K $205.0K $306.9K
YoY Change -87.72% -73.94% -89.24%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.240K
YoY Change -98.95%
Cash & Equivalents $5.666K $1.241K
Short-Term Investments
Other Short-Term Assets $157.4K
YoY Change -0.1%
Inventory
Prepaid Expenses $129.5K $157.4K
Receivables
Other Receivables
Total Short-Term Assets $135.2K $158.6K
YoY Change -14.78% -42.55%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $48.84M
YoY Change -84.34%
Other Assets
YoY Change
Total Long-Term Assets $27.69M $48.84M
YoY Change -43.31% -84.34%
TOTAL ASSETS
Total Short-Term Assets $135.2K $158.6K
Total Long-Term Assets $27.69M $48.84M
Total Assets $27.82M $49.00M
YoY Change -43.22% -84.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $2.365M
YoY Change 151.56%
Deferred Revenue
YoY Change
Short-Term Debt $2.573M
YoY Change 894.36%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.411M $5.028M
YoY Change 67.28% 319.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $11.29M
YoY Change -2.38%
Total Long-Term Liabilities $11.29M
YoY Change -2.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.411M $5.028M
Total Long-Term Liabilities $11.29M
Total Liabilities $19.56M $16.32M
YoY Change 19.84% 27.84%
SHAREHOLDERS EQUITY
Retained Earnings -$19.42M -$16.16M
YoY Change 20.18% 29.4%
Common Stock $2.524M
YoY Change 173.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.42M -$18.99M -$16.16M
YoY Change
Total Liabilities & Shareholders Equity $27.82M $49.00M
YoY Change -43.22% -84.3%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q3
OPERATING ACTIVITIES
Net Income $37.70K $205.0K $306.9K
YoY Change -87.72% -73.94% -89.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$30.93K
YoY Change -48.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$454.3K
YoY Change
Cash From Investing Activities -$454.3K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 478.7K
YoY Change 1452.64%
NET CHANGE
Cash From Operating Activities -30.93K
Cash From Investing Activities -454.3K
Cash From Financing Activities 478.7K
Net Change In Cash -6.500K
YoY Change -77.72%
FREE CASH FLOW
Cash From Operating Activities -$30.93K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39945
dei Entity Registrant Name
EntityRegistrantName
CONSTELLATION ACQUISITION CORP I
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1574835
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Park Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
32nd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10166
dei City Area Code
CityAreaCode
(646)
dei Local Phone Number
LocalPhoneNumber
585-8975
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5666 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3541 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
129527 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
33411 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
135193 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
36952 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
27686372 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
49857596 usd
CY2024Q3 us-gaap Assets
Assets
27821565 usd
CY2023Q4 us-gaap Assets
Assets
49894548 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3668072 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3080658 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8411280 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6558866 usd
CY2024Q3 csta Deferred Underwriting Fees
DeferredUnderwritingFees
10850000 usd
CY2023Q4 csta Deferred Underwriting Fees
DeferredUnderwritingFees
10850000 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
297829 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
300199 usd
CY2024Q3 us-gaap Liabilities
Liabilities
19559109 usd
CY2023Q4 us-gaap Liabilities
Liabilities
17709065 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
27686372 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
49857596 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19424691 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17672888 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-19423916 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-17672113 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27821565 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49894548 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244972 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
731336 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1259173 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2358175 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-244972 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-731336 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1259173 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2358175 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
310320 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
553975 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1005309 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2460396 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
27649 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-484270 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2370 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31600 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
282671 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1038245 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1007679 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2491996 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
37699 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
306909 usd
us-gaap Net Income Loss
NetIncomeLoss
-251494 usd
us-gaap Net Income Loss
NetIncomeLoss
133821 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-17672113 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
553991 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-494150 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-18720254 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
470998 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
204957 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-18986295 usd
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
475320 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
37699 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-19423916 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12485579 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1819906 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-959558 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-15265043 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
986515 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
786470 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-15465088 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1003975 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
306909 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-16162154 usd
us-gaap Net Income Loss
NetIncomeLoss
-251494 usd
us-gaap Net Income Loss
NetIncomeLoss
133821 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1005309 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2460396 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2370 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31600 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
96116 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
123942 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
587414 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1391187 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
90000 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
90000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-677875 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1000930 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
495000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1350000 usd
csta Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
23671533 usd
csta Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
269485746 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23176533 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
268135746 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
31572 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1125000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
50000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2346000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
23671533 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
269485746 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22496533 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-267171318 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2125 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-36502 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3541 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37743 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5666 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1241 usd
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
310000000 usd
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2021Q1 us-gaap Maturity Of Time Deposits
MaturityOfTimeDeposits
P185D
CY2021Q1 csta Percentage Of Public Shareholding To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicShareholdingToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1 pure
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2023Q1 us-gaap Sponsor Fees
SponsorFees
3000000 usd
us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
26506157 shares
csta Trust Account Price Per Share
TrustAccountPricePerShare
10.17
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
5000001 usd
CY2024Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
9967684 shares
CY2024Q3 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
55000 usd
CY2024Q3 us-gaap Deposits
Deposits
55000 usd
CY2024Q3 us-gaap Time Deposits
TimeDeposits
605000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5666 usd
CY2024Q3 csta Working Capital Deficit
WorkingCapitalDeficit
5095087 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Accordingly, actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability and convertible promissory notes. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.</span></p>
CY2024Q3 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
23671533 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts and a Trust Account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition.</span></p>
CY2024Q3 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
CY2024Q3 csta Transaction Costs
TransactionCosts
17586741 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
314517268 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
269485746 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4826074 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
49857596 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
553991 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
23671533 usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
26740054 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
470998 usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
27211052 usd
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
475320 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
27686372 usd
CY2021Q1 csta Purchase Price Per Unit
PurchasePricePerUnit
10
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
csta Issue Price Or Effective Issue Price
IssuePriceOrEffectiveIssuePrice
9.2
csta Market Value Percentage
MarketValuePercentage
1 pure
csta Newly Issued Price Percentage
NewlyIssuedPricePercentage
1.80 pure
csta Redemption Price Per Warrant
RedemptionPricePerWarrant
0.01
CY2024Q3 csta Warrants Price Per Shares
WarrantsPricePerShares
0.1
csta Prior Written Notice Of Redemption Term
PriorWrittenNoticeOfRedemptionTerm
P30D
csta Redeem Warrants Per Share
RedeemWarrantsPerShare
0.1
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
18
csta Number Of Trading Days
NumberOfTradingDays
P10D
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
1125000 shares
csta Initial Business Combination
InitialBusinessCombination
P1Y
us-gaap Operating Expenses
OperatingExpenses
55000 usd
CY2021Q1 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
10000 usd
CY2024Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
CY2023Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 usd
csta Working Capital Loans
WorkingCapitalLoans
1500000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
150000 usd
CY2023Q1 us-gaap Debt Instrument Issued Principal
DebtInstrumentIssuedPrincipal
450000 usd
CY2023Q1 us-gaap Debt Instrument Repaid Principal
DebtInstrumentRepaidPrincipal
1270000 usd
CY2024Q3 csta Deferred Underwriting Fees
DeferredUnderwritingFees
10850000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
Class B ordinary shares into Class A ordinary shares on a one-for-one basis
csta Percentage Of Shares Outstanding After Conversion From One Class To Another
PercentageOfSharesOutstandingAfterConversionFromOneClassToAnother
0.20 pure
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
289333 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 csta Stock Issued During Period Value Conversion Of Unit
StockIssuedDuringPeriodValueConversionOfUnit
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001834032

Files In Submission

Name View Source Status
0001213900-24-098449-index-headers.html Edgar Link pending
0001213900-24-098449-index.html Edgar Link pending
0001213900-24-098449.txt Edgar Link pending
0001213900-24-098449-xbrl.zip Edgar Link pending
csta-20240930.xsd Edgar Link pending
ea0220387-10q_constella1.htm Edgar Link pending
ea022038701ex31-1_constella1.htm Edgar Link pending
ea022038701ex31-2_constella1.htm Edgar Link pending
ea022038701ex32-1_constella1.htm Edgar Link pending
ea022038701ex32-2_constella1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
csta-20240930_lab.xml Edgar Link unprocessable
csta-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0220387-10q_constella1_htm.xml Edgar Link completed
csta-20240930_cal.xml Edgar Link unprocessable
csta-20240930_def.xml Edgar Link unprocessable